Johnson & Johnson (J&J)

This sponsor has funded 11 studies across 30 countries.

PAS funded by this sponsor.
EU PAS ID Status Title Protocol uploaded Results uploaded
16778 Finalised Yes Yes
23109 Finalised Yes Yes
31269 Ongoing Yes No
31333 Ongoing Yes No
34300 Finalised Yes No
34490 Planned No No
34494 Planned No No
37360 Finalised Yes No
48616 Ongoing Yes No
50081 Planned No No
50570 Finalised Yes Yes

PAS by Risk Management Plan (RMP) requirement

Johnson & Johnson (J&J)

The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.

Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.